SNS Financial Group’s GSK GSK Stock Holding History

SNS Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-41,408	Closed	-$2.23M	–	196
2016 Q3	$2.23M	Buy	41,408 +10,651	+35%	+$584K	0.65%	34
2016 Q2	$1.67M	Buy	+30,757	New	+$1.62M	0.42%	45

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SNS Financial Group's GSK Position: Q4 2016 in Review

SNS Financial Group sold out of GSK (GSK) in Q4 2016, closing a stake of 41,408 shares — an estimated $2.23M sold.

SNS Financial Group first reported a position in GSK in Q2 2016 and held it in 2 quarters. The position peaked at $2.23M in Q3 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

SNS Financial Group reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
SNS Financial Group sold 41,408 GSK shares in Q4 2016, an estimated $2.23M.
SNS Financial Group first reported a position in GSK in Q2 2016 and held it in 2 quarters.
SNS Financial Group's GSK position peaked at $2.23M in Q3 2016.
763 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on SNS Financial Group's 13F filing for Q4 2016, filed 24 Feb 2017.